Wunong Net Technology stock hits 52-week low at $1.35

Published 11/04/2025, 20:22
Wunong Net Technology stock hits 52-week low at $1.35

Wunong Net Technology Co Ltd (WNW) shares tumbled to a 52-week low, touching down at $1.35 amidst a challenging market environment. InvestingPro analysis indicates the stock is currently in oversold territory, with a Price/Book ratio of just 0.3. The stock, which has been under considerable pressure, reflects a stark contrast from its previous performance, marking a significant downturn over the past year. Investors have witnessed a dramatic decline in the company's stock value, with the 1-year change data revealing a staggering -93.71% drop. Despite maintaining a healthy gross profit margin of 45.29% and holding more cash than debt, the company faces challenges with a dramatic 98.14% revenue decline. InvestingPro subscribers can access 15+ additional key insights about WNW's financial health and future prospects.

In other recent news, Meiwu Technology Company Limited has announced a reverse stock split, which will consolidate every 20 existing shares into one new share. This corporate action, approved by the board, is set to take effect on April 1, 2025, and aims to increase the market price of the company's shares. Following the reverse split, the number of outstanding shares will reduce from approximately 63.3 million to about 3.2 million. The company has clarified that shareholders holding pre-split shares electronically will not need to take any action, while those with paper certificates will receive new ones. This move comes as Meiwu Technology faces a potential Nasdaq delisting due to its share price remaining below $1.00 for 30 consecutive business days. To regain compliance, the company must increase its share price to at least $1.00 for 10 consecutive business days before August 26, 2025. Meiwu Technology has not detailed its plans to address this compliance issue, but the possibility of a reverse stock split was mentioned. These developments follow the company's strategic shift to the skincare industry through its subsidiary, Xiamen Chunshang Health Technology Co., Ltd.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.